Search Within

Virginia Bowen Kelly

Formats
  1. Meeting Abstract (10)
  2. Journal Article (3)
Groups
  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Solid Tumor Oncology Division (13)
  5. Weinberg Fellows (13)
  6. Department of Pathology and Laboratory Medicine (7)

More Groups

People
  1. Diane Reidy (13)
  2. Nitya Raj (13)
  3. Brian Untch (5)
  4. Joanne Chou (5)
  5. Michael Berger (5)
  6. Anuradha Gopalan (4)

More People

Years
  1. 2021 (1)
  2. 2020 (3)
  3. 2019 (5)
  4. 2018 (4)
Publications
  1. Journal of Clinical Oncology (9)
  2. Pancreas (2)
  3. JCO Precision Oncology (1)
  4. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (10)
  2. Lippincott Williams & Wilkins (2)
  3. Oxford University Press (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Temozolomide in grade 3 gastroenteropancreatic neuroendocrine neoplasms: A multicenter retrospective review
    Journal Article

    Chan, D. L.; Bergsland, E. K.; Chan, J. A.; Gadgil, R.; Halfdanarson, T. R.; Hornbacker, K.; Kelly, V.; Kunz, P. L.; McGarrah, P. W.; Raj, N. P.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J.; Do, R.; Capanu, M.; Zamarin, D.; Saltz, L.; Ariyan, C.; more...
    Pancreas (2020)

    Fulltext@MSK | Save
  • Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (PanNETS)
    Meeting Abstract

    Wu, Y. L.; Reidy, D.; Bielska, A.; Kelly, V.; Raj, N.
    Pancreas (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Outcomes after cessation of therapy with alkylating agents (AA) for pancreatic neuroendocrine tumors (panNETs)
    Meeting Abstract

    Wu, L.; Reidy, D. L.; Bielska, A.; Kelly, V.; Raj, N. P.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone)
    Meeting Abstract

    Mulvey, C.; Raj, N. P.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T. A.; Kolli, K.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review
    Meeting Abstract

    Chan, D.; Bergsland, E. K.; Chan, J. A.; Gadgil, R.; Halfdanarson, T. R.; Hornbacker, K.; Kelly, V.; Kunz, P. L.; McGarrah, P. W.; Raj, N. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Predictors of treatment response in colorectal high-grade neuroendocrine carcinomas (HGNEC): A single institution experience
    Meeting Abstract

    Corbett, V.; Raj, N. P.; Kelly, V.; Reidy, D. L.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing
    Meeting Abstract

    Akala, O. O.; Kelly, V.; Strong, V. E.; Gopalan, A.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save